Last quarter (Q2 2022), BB Biotech's total revenue was CHF-222.52M, a decrease of -159.06% from the same quarter last year. In Q2, BB Biotech's net income was CHF-233.06M. See BB Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	CHF -184.40M	CHF -351.23M	CHF -396.22M	CHF 699.23M	CHF 685.24M	CHF -465.75M
Credit Losses Provision	-	-	-	-	-	-
Non Interest Expense	-	-	-	-	-	-
Incomefrom Associatesand Other Participating Interests	-	-	-	-	-	-
Special Income Charges	-	-	-	-	-	-
Pretax Income	CHF -208.53M	CHF -357.75M	CHF -404.74M	CHF 691.25M	CHF 677.50M	CHF -471.27M
Tax Provision	CHF 68.00K	CHF 61.00K	CHF 67.00K	CHF 75.00K	CHF 68.00K	CHF 71.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	CHF -208.59M	CHF -357.81M	CHF -404.81M	CHF 691.17M	CHF 677.43M	CHF -471.34M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Interest Income After Provision For Loan Loss	-	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	CHF -208.59M	CHF -357.81M	CHF -404.81M	CHF 691.17M	CHF 677.43M	CHF -471.34M
Normalized Income	CHF -208.59M	CHF -357.81M	CHF -404.81M	CHF 691.17M	CHF 677.43M	CHF -471.34M
Total Money Market Investments	-	-	-	-	-	-
Ebit	-	-	-	-	-	-
Ebitda	-	-	-	-	-	-

Currency in CHF

BB Biotech Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing